vs

Side-by-side financial comparison of Baird Medical Investment Holdings Ltd (BDMD) and Citizens Community Bancorp Inc. (CZWI). Click either name above to swap in a different company.

Citizens Community Bancorp Inc. is the larger business by last-quarter revenue ($15.8M vs $8.0M, roughly 2.0× Baird Medical Investment Holdings Ltd). Citizens Community Bancorp Inc. runs the higher net margin — 27.1% vs -142.7%, a 169.8% gap on every dollar of revenue. Citizens Community Bancorp Inc. produced more free cash flow last quarter ($10.4M vs $-3.2M).

Baird Medical Investment Holdings Ltd is a healthcare-focused investment holding company mainly operating in the Chinese market. It invests in and manages businesses covering in vitro diagnostic devices, medical consumables, and community healthcare services, serving clinical institutions and individual consumers.

Glacier Bancorp, Inc. is a regional multi-bank holding company headquartered in Kalispell, Montana, United States. It is a successor corporation to the Delaware corporation originally incorporated in 1990. The company provides personal and commercial banking services from 221 locations in Montana, Idaho, Utah, Washington, Wyoming, Colorado, Arizona, and, Nevada.

BDMD vs CZWI — Head-to-Head

Bigger by revenue
CZWI
CZWI
2.0× larger
CZWI
$15.8M
$8.0M
BDMD
Higher net margin
CZWI
CZWI
169.8% more per $
CZWI
27.1%
-142.7%
BDMD
More free cash flow
CZWI
CZWI
$13.6M more FCF
CZWI
$10.4M
$-3.2M
BDMD

Income Statement — Q2 FY2025 vs Q4 FY2025

Metric
BDMD
BDMD
CZWI
CZWI
Revenue
$8.0M
$15.8M
Net Profit
$-11.4M
$4.3M
Gross Margin
82.1%
Operating Margin
-131.3%
31.0%
Net Margin
-142.7%
27.1%
Revenue YoY
14.9%
Net Profit YoY
58.1%
EPS (diluted)
$0.44

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BDMD
BDMD
CZWI
CZWI
Q4 25
$15.8M
Q3 25
$16.2M
Q2 25
$8.0M
$16.1M
Q1 25
$14.2M
Q4 24
$13.7M
Q3 24
$14.2M
Q2 24
$13.5M
Q1 24
$15.2M
Net Profit
BDMD
BDMD
CZWI
CZWI
Q4 25
$4.3M
Q3 25
$3.7M
Q2 25
$-11.4M
$3.3M
Q1 25
$3.2M
Q4 24
$2.7M
Q3 24
$3.3M
Q2 24
$3.7M
Q1 24
$4.1M
Gross Margin
BDMD
BDMD
CZWI
CZWI
Q4 25
Q3 25
Q2 25
82.1%
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Operating Margin
BDMD
BDMD
CZWI
CZWI
Q4 25
31.0%
Q3 25
27.9%
Q2 25
-131.3%
25.1%
Q1 25
28.0%
Q4 24
24.5%
Q3 24
29.5%
Q2 24
35.0%
Q1 24
34.2%
Net Margin
BDMD
BDMD
CZWI
CZWI
Q4 25
27.1%
Q3 25
22.7%
Q2 25
-142.7%
20.3%
Q1 25
22.5%
Q4 24
19.7%
Q3 24
23.1%
Q2 24
27.2%
Q1 24
26.9%
EPS (diluted)
BDMD
BDMD
CZWI
CZWI
Q4 25
$0.44
Q3 25
$0.37
Q2 25
$0.33
Q1 25
$0.32
Q4 24
$0.28
Q3 24
$0.32
Q2 24
$0.35
Q1 24
$0.39

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BDMD
BDMD
CZWI
CZWI
Cash + ST InvestmentsLiquidity on hand
$118.9M
Total DebtLower is stronger
$8.4M
$51.8M
Stockholders' EquityBook value
$35.6M
$187.9M
Total Assets
$77.0M
$1.8B
Debt / EquityLower = less leverage
0.24×
0.28×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BDMD
BDMD
CZWI
CZWI
Q4 25
$118.9M
Q3 25
$82.4M
Q2 25
$67.5M
Q1 25
$100.2M
Q4 24
$50.2M
Q3 24
$36.6M
Q2 24
$36.9M
Q1 24
$28.6M
Total Debt
BDMD
BDMD
CZWI
CZWI
Q4 25
$51.8M
Q3 25
Q2 25
$8.4M
Q1 25
Q4 24
$66.6M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
BDMD
BDMD
CZWI
CZWI
Q4 25
$187.9M
Q3 25
$186.8M
Q2 25
$35.6M
$183.5M
Q1 25
$180.1M
Q4 24
$179.1M
Q3 24
$180.1M
Q2 24
$176.0M
Q1 24
$172.8M
Total Assets
BDMD
BDMD
CZWI
CZWI
Q4 25
$1.8B
Q3 25
$1.7B
Q2 25
$77.0M
$1.7B
Q1 25
$1.8B
Q4 24
$1.7B
Q3 24
$1.8B
Q2 24
$1.8B
Q1 24
$1.8B
Debt / Equity
BDMD
BDMD
CZWI
CZWI
Q4 25
0.28×
Q3 25
Q2 25
0.24×
Q1 25
Q4 24
0.37×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BDMD
BDMD
CZWI
CZWI
Operating Cash FlowLast quarter
$-3.2M
$11.7M
Free Cash FlowOCF − Capex
$-3.2M
$10.4M
FCF MarginFCF / Revenue
-40.7%
65.9%
Capex IntensityCapex / Revenue
0.6%
8.3%
Cash ConversionOCF / Net Profit
2.74×
TTM Free Cash FlowTrailing 4 quarters
$17.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BDMD
BDMD
CZWI
CZWI
Q4 25
$11.7M
Q3 25
$6.6M
Q2 25
$-3.2M
$-406.0K
Q1 25
$1.6M
Q4 24
$20.4M
Q3 24
$3.5M
Q2 24
$5.1M
Q1 24
$9.1M
Free Cash Flow
BDMD
BDMD
CZWI
CZWI
Q4 25
$10.4M
Q3 25
$6.2M
Q2 25
$-3.2M
$-632.0K
Q1 25
$1.5M
Q4 24
$19.5M
Q3 24
$3.4M
Q2 24
$4.8M
Q1 24
$8.9M
FCF Margin
BDMD
BDMD
CZWI
CZWI
Q4 25
65.9%
Q3 25
38.4%
Q2 25
-40.7%
-3.9%
Q1 25
10.7%
Q4 24
142.2%
Q3 24
23.8%
Q2 24
35.7%
Q1 24
58.9%
Capex Intensity
BDMD
BDMD
CZWI
CZWI
Q4 25
8.3%
Q3 25
2.4%
Q2 25
0.6%
1.4%
Q1 25
0.7%
Q4 24
6.5%
Q3 24
0.9%
Q2 24
2.3%
Q1 24
1.4%
Cash Conversion
BDMD
BDMD
CZWI
CZWI
Q4 25
2.74×
Q3 25
1.80×
Q2 25
-0.12×
Q1 25
0.50×
Q4 24
7.55×
Q3 24
1.07×
Q2 24
1.39×
Q1 24
2.24×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons